Funding for this research was provided by:
Metastatic Breast Cancer Research Fund at Rush
Text and Data Mining valid from 2019-07-16
Received: 2 May 2019
Accepted: 27 June 2019
First Online: 16 July 2019
Ethics approval and consent to participate
: This study was approved by the Rush University Medical Center Institutional Review Board, Office of Research Affairs. Patients have provided informed consent for use of their archival tissue. Patients were made aware that the data collected is available on an individual basis. The IRB human subjects’ protection division designated this study as low risk to subjects with deidentification of data, once recorded so that subjects cannot be linked directly or by an identifier to the data reported.
: The authors warrant that the manuscript does not infringe upon any copyright or other right(s), and that we are the sole and exclusive owners of the rights conveyed to Hereditary Cancer in Clinical Practice. The authors guarantee that the contribution to the work has not been previously published elsewhere.
: The authors have disclosed that they have no financial interests, arrangements, affiliations, or commercial interests with the manufacturers of any products discussed in this article or their competitors.